Abstract
ABSTRACTChronic liver disease has reached epidemic proportions, affecting over 800 million people globally. The current treatment, orthotopic liver transplantation, has several limitations. Promising solutions have emerged in the field of liver regenerative medicine, with liver organogenesis holding significant potential. Early liver organogenesis, occurring between E8.5 and 11.5, involves the formation of epithelial-mesenchymal interactions leading to morphogenesis, hepatic cord formation, and collective migration. However, there is a lack of methods forin vitromodeling of this process. In this study, a detailed series of methods are presented enabling the modeling of various stages and aspects of liver organogenesis. In one method series, assembloid technology with hepatic and mesenchymal spheroids is utilized, replicating early structures found in liver organogenesis, modeling early morphogenesis, and demonstrating interstitial cell migration as seenin vivo. These innovative assembloid systems help identify factors influencing assembloid formation and migration. Hepatic spheroid cultivation systems were also employed to model collective migration and branching morphogenesis. Fibroblast-conditioned media (MES-CM) plays a significant role in initiating dose-dependent branching migration. Future work will involve high temporal and spatial resolution imaging of hepatic and mesenchymal interactions to determine the cascade of cellular and molecular events involved in tissue formation, morphogenesis, and migration.SUMMARYOrganoids revolutionize personalized tissue modeling for organ development, drug discovery, and disease research. Organoid engineering advances into creating intricate synthetic tissues. The aim is to integrate morphogenesis, assembloid technology, and biomatrices to advance tissue engineering. The presented methods aid in modeling liver organogenesis and establishing guidelines for synthetic tissue construction.
Publisher
Cold Spring Harbor Laboratory